Indian govt bans Saridon, 327 other combination drugs
The health ministry of India has, with immediate effect, put a ban on manufacture, sale, and distribution of 328 fixed-dose combinations (FDCs) of drugs and restricted another six. This marks an end of the legal battle between the ministry and the manufacturers of these drugs. The ministry has been working since 2016 to ban these “irrational” and “unsafe” drugs. Among the roughly 6,000 brands estimated to be affected by the ban are popular drugs like the painkiller Saridon, the skin cream Panderm, combination diabetes drug Gluconorm, antibiotic Lupidicl, x and antibacterial Taxim AZ. The government had banned 344 FDCs on March 10, 2016, and later added five more to this list. Read More
Bayer Animal Health GmbH and NeuroCycle Therapeutics Inc (NCT) have signed a global license agreement to advance innovative allergy treatment options for companion animals. As part of the license agreement, Bayer will develop and commercialize novel compounds based on knowledge and intellectual property licensed and controlled by NCT. Pet ownership is growing around the world and with that customers’ requirement for more effective and convenient treatment options. “At Bayer, we are committed to help pet owners improve the health and well-being of their animals. We know that allergies are among the most important health and well-being concerns for pet owners and veterinarians. Read More
Clariant said that it was listed in the Dow Jones Sustainability Index (DJSI) 2018. This marks the 6th consecutive year that Clariant was recognized as one of the most sustainable chemical companies worldwide and is a testament to the company’s long-standing commitment to sustainability. The analysts at RobecoSAM confirmed Clariant as best in class in the categories of Materiality, Environmental Reporting, Water Related Risks and Human Capital Development and therefore across all three dimensions of the assessment. Clariant was ranked among the top companies in the chemical sector in both the DJSI Europe and the DJSI World. Clariant continuously steers its activities and product portfolio to create additional value for customers and contribute positively to global sustainable development. Read More
Fluor Corporation (FLR) said that the US Department of Energy (DOE) has exercised its option to extend its current management and operating contract of the Strategic Petroleum Reserve (SPR) through 31 March 2024. The contract is currently being executed by Fluor Federal Petroleum Operations, LLC (FFPO), a wholly-owned subsidiary of Fluor. Fluor will book the $2 billion contract extension value in the third quarter of 2018. FFPO began management and operations work on the SPR on April 1, 2014. As a result of this contract extension, Fluor will continue to support DOE in the execution of the SPR’s life extension engineering and construction efforts. The SPR is the world’s largest supply of emergency crude oil. Read More